
How to Source Pharmaceutical APIs and Ingredients from China Safely
An API is a drug, not a chemical โ and a supplier that is not on the CDE registration platform with an approved 'A' status cannot legally supply you a registered API. How the registration-plus-associated-review system works, and how to verify the licence, the GMP status and the export certificate.
Sourcing a pharmaceutical active ingredient is not like sourcing a finished consumer product. The substance is regulated as a drug in China, the supplier must hold a production licence and pass GMP compliance inspection, and the ingredient must be registered on the CDE platform with an approved status before it can be used in a finished drug. A buyer who treats an API purchase like an ordinary chemical purchase ends up with an unregistered substance it cannot use โ or worse, a customs and drug-regulatory problem in its own market. The checks below separate a legitimate API maker from a middleman selling a chemical under a drug name.
APIs are drugs: registration plus associated review, not just filing
Under the Drug Administration Law (2019 revision) and the Measures for the Administration of Drug Registration (effective 1 July 2020), an API is approved through registration on the CDE platform combined with associated review and approval (ๅ ณ่ๅฎก่ฏๅฎกๆน) alongside the finished drug โ the operative provisions are Articles 41 to 44 of the registration measures. The accurate description is registration plus associated review, not a simple filing: once approved, the API receives a Chemical API Approval Notice with a registration number beginning with 'Y', and its CDE platform status is marked 'A' (approved) or 'I' (not approved or lapsed). A supplier whose API shows 'I' status, or which has no registration number at all, cannot lawfully supply a registered API for a finished drug.
Production licence and GMP compliance inspection
An API manufacturer must hold a Drug Manufacturing Licence whose production scope covers the specific API, and its production site, workshop and line must have passed a GMP compliance inspection. Note the terminology: since the 2019 Drug Administration Law, there is no separate 'GMP certificate' โ the requirement is a passed GMP compliance inspection recorded by the regulator. Ask the supplier for the manufacturing licence and the GMP compliance inspection result for the exact production line, not a framed certificate from years ago.
The export certificate: new rules from 2026
For export, a Drug Export Sales Certificate (่ฏๅๅบๅฃ้ๅฎ่ฏๆ) is required. The rules changed recently: NMPA Announcement No. 113 of 2025, effective 1 January 2026, replaced the older export-certificate rules, extended the certificate's validity from two years to three, and covers preparations, APIs and TCM formula granules, with intermediate products eligible by reference. A buyer should confirm the supplier holds a current export sales certificate under the 2026 rules โ the old two-year, 2018-era certificate references are outdated.
Verify the supplier in official databases
- CDE chemical API registration platform (cde.org.cn) โ check the registration number, the 'A' status, the company name and the production address.
- NMPA drug data query system โ check the Drug Manufacturing Licence and the GMP compliance inspection information.
- Cross-check the legal entity, the production address and the registration number against the contract, so you are not buying from a trader using a borrowed registration.
The boundary: API vs excipient vs food ingredient
The same substance can sit in different regulatory lanes depending on its intended use, and the use decides the regime. An API is regulated as a drug (registration number beginning with 'Y'); a pharmaceutical excipient or packaging material is subject to associated-review registration with a different code ('F' for excipients, 'B' for packaging materials); and a food additive or food ingredient is regulated under the Food Safety Law with a food production licence, not the drug regime. If your product is a dietary supplement or a food rather than a drug in the destination market, you need the food path and the food export documents โ do not accept a drug export certificate for a food-grade purchase, or vice versa.
A supplier that quotes an API price but cannot show a 'Y' registration number, an 'A' status on the CDE platform, or a manufacturing licence covering the exact API โ or that offers a drug export certificate for a food-grade order โ is blurring the regulatory line. Verify the registration, the licence and the certificate before you pay. This content is general information and not legal advice.
Sourcing pharmaceutical APIs safely is a registration-and-licence discipline. Confirm the CDE registration and 'A' status, the manufacturing licence and GMP compliance inspection, and the 2026 export certificate, and keep the API, excipient and food-ingredient lanes separate. The buyer who does that buys a usable, lawful ingredient; the buyer who skips it buys a regulatory problem.
Related guides
Verify a supplier now
Run due diligence on a Chinese supplier before you pay.
